Published 3 days ago • loading... • Updated 3 days agoShow Less IconUnited Therapeutics: The Market Sees The Erosion, Not The Refill - Buy (NASDAQ:UTHR) Summary by Seeking AlphaUnited Therapeutics' declines are real but they sit in ~32% of the business, tax-normalized earnings power is $1.05 billion. See why UTHR stock is a Buy now.Share menu1 Articles1 ArticlesAllLeftCenterRight1Search IconSort IconSeeking AlphaLean RightFactualityOwnershipUnited Therapeutics: The Market Sees The Erosion, Not The Refill - Buy (NASDAQ:UTHR)United Therapeutics' declines are real but they sit in ~32% of the business, tax-normalized earnings power is $1.05 billion. See why UTHR stock is a Buy now.3 days ago·Ra'anana, IsraelRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right1Center0Last Updated3 days agoBias Distribution100% RightBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources lean Right100% RightR 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageSeeking Alpha broke the news in Ra'anana, Israel 3 days ago on Sunday, September 27, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsSilver Spring Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsSilver Spring Plus IconShow All